NASDAQ : CTXR
Citius Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.5231 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.36M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 56.94M | 29.37M | 30.09M | 21.91M | 15.66M | 11.29M |
| Research & Development | 5.93M | 9.16M | 11.91M | 14.82M | 17.66M | 12.24M |
| Operating Expenses | 62.86M | 38.53M | 42.00M | 36.73M | 33.32M | 23.53M |
| Operating Income | -57.37M | -38.53M | -42.00M | -36.73M | -33.32M | -23.53M |
| Interest Expense | -695.31K | -267.78K | -10.84K | |||
| Interest & Investment Income | 268.80K | 110.08K | 758.00K | 1.18M | 251.40K | 261.82K |
| EBT Excluding Unusual Items | -57.80M | -38.68M | -41.24M | -35.55M | -33.06M | -23.28M |
| Gain (Loss) on Sale of Assets | 3.83M | 2.39M | 3.59M | |||
| Other Unusual Items | 226.47K | |||||
| Pretax Income | -57.98M | -38.68M | -38.85M | -31.97M | -33.06M | -23.05M |
| Income Tax Expense | 189.92K | 1.06M | 576.00K | 576.00K | 576.00K | |
| Earnings From Continuing Operations | -58.17M | -39.74M | -39.43M | -32.54M | -33.64M | -23.05M |
| Minority Interest in Earnings | 11.89M | 2.31M | 287.00K | |||
| Net Income | -46.27M | -37.43M | -39.14M | -32.54M | -33.64M | -23.05M |
| Preferred Dividends & Other Adjustments | 1.05M | 1.15M | 1.45M | |||
| Net Income to Common | -46.27M | -37.43M | -40.19M | -33.69M | -33.64M | -24.51M |
| Shares Outstanding (Basic) | 21.81M | 11.07M | 6.73M | 6.05M | 5.84M | 4.34M |
| Shares Outstanding (Diluted) | 21.81M | 11.07M | 6.73M | 6.05M | 5.84M | 4.34M |
| EPS (Basic) | -2.12 | -3.38 | -5.97 | -5.57 | -5.76 | -5.64 |
| EPS (Diluted) | -2.12 | -3.38 | -5.97 | -5.57 | -5.76 | -5.64 |
| Free Cash Flow | -34.87M | -26.55M | -28.20M | -29.06M | -28.36M | -24.26M |
| Free Cash Flow Per Share | -1.60 | -2.40 | -4.19 | -4.80 | -4.85 | -5.58 |
| EBITDA | -38.52M | -41.99M | -36.73M | -33.31M | -23.53M | |
| D&A For EBITDA | 1.43K | 1.43K | 2.67K | 2.92K | 1.49K | |
| EBIT | -57.37M | -38.53M | -42.00M | -36.73M | -33.32M | -23.53M |
Balance sheet
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 17.01M | 4.25M | 3.25M | 26.48M | 41.71M | 70.07M |
| Cash & Short-Term Investments | 17.01M | 4.25M | 3.25M | 26.48M | 41.71M | 70.07M |
| Receivables | 686.24K | |||||
| Inventory | 22.63M | 22.29M | 8.27M | |||
| Prepaid Expenses | 3.01M | 1.40M | 2.70M | 7.89M | 2.85M | 2.74M |
| Total Current Assets | 43.33M | 27.93M | 14.22M | 34.37M | 44.56M | 72.81M |
| Property, Plant & Equipment | 753.04K | 818.69K | 246.25K | 455.86K | 650.17K | 829.85K |
| Goodwill | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
| Other Intangible Assets | 88.79M | 92.80M | 92.80M | 59.40M | 59.40M | 59.40M |
| Other Long-Term Assets | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K |
| Total Assets | 142.26M | 130.94M | 116.65M | 103.61M | 114.00M | 142.43M |
| Accounts Payable | 8.04M | 13.69M | 4.93M | 2.93M | 1.17M | 1.28M |
| Accrued Expenses | 27.79M | 7.48M | 2.25M | 2.63M | 3.17M | 2.53M |
| Short-Term Debt | 1.00M | |||||
| Current Portion of Leases | 176.17K | 88.35K | 241.55K | 218.38K | 196.99K | 177.24K |
| Other Current Liabilities | 15.65M | 22.65M | 28.40M | |||
| Total Current Liabilities | 51.65M | 44.91M | 35.81M | 5.78M | 4.53M | 3.98M |
| Long-Term Debt | 6.41M | |||||
| Long-Term Leases | 590.79K | 724.92K | 21.32K | 262.87K | 481.25K | 678.23K |
| Long-Term Deferred Tax Liabilities | 7.70M | 7.77M | 6.71M | 6.14M | 5.56M | 4.99M |
| Total Liabilities | 66.35M | 53.41M | 42.55M | 12.18M | 10.57M | 9.65M |
| Common Stock | 27.45K | 18.07K | 7.25K | 6.35K | 146.21K | 145.98K |
| Additional Paid-In Capital | 343.70M | 306.34M | 271.44M | 253.06M | 232.37M | 228.08M |
| Retained Earnings | -277.12M | -238.80M | -201.37M | -162.23M | -129.69M | -96.05M |
| Total Common Equity | 66.61M | 67.55M | 70.08M | 90.83M | 102.83M | 132.18M |
| Minority Interest | 9.30M | 9.98M | 4.02M | 600.38K | 600.38K | 600.38K |
| Shareholders' Equity | 75.91M | 77.53M | 74.10M | 91.43M | 103.43M | 132.78M |
| Total Liabilities & Equity | 142.26M | 130.94M | 116.65M | 103.61M | 114.00M | 142.43M |
| Total Debt | 7.18M | 1.81M | 262.87K | 481.25K | 678.23K | 855.47K |
| Net Cash (Debt) | 9.83M | 2.44M | 2.99M | 26.00M | 41.03M | 69.22M |
| Net Cash Per Share | 0.45 | 0.22 | 0.44 | 4.30 | 7.02 | 15.93 |
| Filing Date Shares Outstanding | 27.45M | 20.76M | 7.73M | 6.36M | 5.85M | 5.84M |
| Total Common Shares Outstanding | 27.45M | 18.07M | 7.25M | 6.35M | 5.85M | 5.84M |
| Working Capital | -8.32M | -16.98M | -21.59M | 28.59M | 40.03M | 68.83M |
| Book Value Per Share | 2.43 | 3.74 | 9.67 | 14.29 | 17.58 | 22.64 |
| Tangible Book Value | -31.52M | -34.60M | -32.07M | 22.08M | 34.08M | 63.44M |
| Tangible Book Value Per Share | -1.15 | -1.91 | -4.43 | 3.48 | 5.83 | 10.86 |
Cash flow statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -46.27M | -37.43M | -39.14M | -32.54M | -33.64M | -23.05M |
| Depreciation & Amortization | 127.69K | 214.25K | 209.61K | 194.32K | 179.68K | 164.87K |
| Stock-Based Compensation | 14.97M | 10.86M | 12.12M | 6.72M | 4.28M | 1.52M |
| Other Operating Activities | -11.70M | -1.25M | 289.00K | 576.00K | 576.00K | -166.56K |
| Change in Accounts Receivable | -686.24K | |||||
| Change in Inventory | -4.05M | -12.65M | -2.13M | |||
| Change in Accounts Payable | -2.06M | 8.77M | 2.00M | 1.76M | -111.72K | -579.14K |
| Change in Other Net Operating Assets | 10.61M | 4.94M | -1.55M | -5.77M | 351.27K | -2.14M |
| Operating Cash Flow | -34.87M | -26.55M | -28.20M | -29.06M | -28.36M | -24.25M |
| Capital Expenditures | -6.94K | |||||
| Sale (Purchase) of Intangibles | -12.75M | -5.75M | -5.00M | -40.00M | ||
| Investing Cash Flow | -12.75M | -5.75M | -5.00M | -40.01M | ||
| Short-Term Debt Issued | 1.30M | |||||
| Total Debt Issued | 9.63M | 1.30M | ||||
| Short-Term Debt Repaid | -300.00K | -172.97K | ||||
| Total Debt Repaid | -1.00M | -300.00K | -172.97K | |||
| Net Debt Issued (Repaid) | 8.63M | 1.00M | -172.97K | |||
| Issuance of Common Stock | 50.79M | 32.30M | 13.80M | 15.03M | 127.71M | |
| Other Financing Activities | -892.55K | -3.83M | -1.20M | -7.07M | ||
| Financing Cash Flow | 58.54M | 33.30M | 9.97M | 13.83M | 120.47M | |
| Net Cash Flow | 10.92M | 1.00M | -23.23M | -15.23M | -28.36M | 56.21M |
| Free Cash Flow | -34.87M | -26.55M | -28.20M | -29.06M | -28.36M | -24.26M |
| Free Cash Flow Per Share | -1.60 | -2.40 | -4.19 | -4.80 | -4.85 | -5.58 |
| Levered Free Cash Flow | -36.80M | -23.38M | 8.02M | -19.85M | -15.94M | -55.61M |
| Unlevered Free Cash Flow | -36.55M | -23.21M | 8.02M | -19.85M | -15.94M | -55.61M |
| Cash Interest Paid | 491.03K | 187.39K | 38.92K | |||
| Change in Working Capital | 3.82M | 1.05M | -1.69M | -4.01M | 239.56K | -2.72M |
Ratios
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 15.27M | 21.10M | 90.47M | 108.72M | 176.82M | 296.34M |
| Enterprise Value | 5.44M | 19.39M | 73.48M | 76.57M | 130.10M | 182.34M |
| Last Close Price | 0.52 | 1.24 | 12.52 | 17.11 | 30.25 | 50.75 |
| Forward PE | 1.37 | 8.71 | 7.11 | 7.11 | 7.88 | |
| PB Ratio | 0.22 | 0.27 | 1.22 | 1.19 | 1.71 | 2.23 |
| P/TBV Ratio | 4.92 | 5.19 | 4.67 | |||
| Debt / Equity Ratio | 0.10 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -0.13 | -0.03 | -0.04 | -0.28 | -0.40 | -0.52 |
| Net Debt / EBITDA Ratio | 0.06 | 0.07 | 0.71 | 1.23 | 2.94 | |
| Net Debt / FCF Ratio | 0.28 | 0.09 | 0.11 | 0.90 | 1.45 | 2.85 |
| Quick Ratio | 0.34 | 0.10 | 0.09 | 4.58 | 9.21 | 17.60 |
| Current Ratio | 0.84 | 0.62 | 0.40 | 5.95 | 9.84 | 18.29 |
| Return on Equity (ROE) | -81.09% | -52.42% | -47.63% | -33.40% | -28.48% | -27.70% |
| Return on Assets (ROA) | -26.57% | -19.45% | -23.83% | -21.10% | -16.24% | -15.80% |
| Return on Capital Employed (ROCE) | -63.30% | -44.80% | -52.00% | -37.50% | -30.40% | -17.00% |
| Earnings Yield | -381.50% | -177.45% | -43.26% | -29.93% | -19.03% | -7.78% |
| FCF Yield | -237.44% | -125.87% | -31.17% | -26.73% | -16.04% | -8.19% |
| Buyback Yield / Dilution | -154.35% | -64.49% | -11.16% | -3.57% | -34.52% | -177.28% |